Stefanie Huhn

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Journal: Nature medicine
Published: July 06, 2026

Erratum: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Erratum: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 08, 2026

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 21, 2026

Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.

Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.

Journal: Blood advances
Published: September 30, 2025

Fiber intake associates with increased treatment response in multiple myeloma patients along changes in gut microbiome.

Fiber intake associates with increased treatment response in multiple myeloma patients along changes in gut microbiome.

Journal: Blood advances
Published: September 30, 2025

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Journal: Nature medicine
Published: September 26, 2025

Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.

Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.

Journal: Science immunology
Published: February 07, 2025

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 09, 2024

Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.

Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.

Journal: bioRxiv : the preprint server for biology
Published: September 16, 2024

The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.

The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.

Journal: Blood
Published: February 13, 2024

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Journal: Nature genetics
Published: January 29, 2024

Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.

Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: January 11, 2024
Showing 1-12 of 59

Last Updated: 09/26/2026